ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
2.620
-0.050 (-1.87%)
Dec 20, 2024, 4:00 PM EST - Market closed
ImmunityBio Analyst Ratings
Total Analysts
2
Consensus Rating
Buy
Price Target
$17.38
Upside
+563.36%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $30 | Strong Buy | Maintains | $30 | +1,045.04% | Dec 20, 2024 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $30 | Strong Buy | Maintains | $30 | +1,045.04% | Nov 21, 2024 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $30 | Strong Buy | Maintains | $30 | +1,045.04% | Nov 19, 2024 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $30 | Strong Buy | Maintains | $30 | +1,045.04% | Nov 12, 2024 |
| EF Hutton | EF Hutton | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +1,045.04% | Oct 23, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $6 → $4.75 | Hold | Maintains | $6 → $4.75 | +81.30% | Aug 19, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $5 → $6 | Hold | Maintains | $5 → $6 | +129.01% | Apr 29, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $4 → $5 | Hold | Maintains | $4 → $5 | +90.84% | Mar 25, 2024 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $10 → $4 | Buy → Hold | Downgrades | $10 → $4 | +52.67% | May 12, 2023 |
| Jefferies | Jefferies | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +205.34% | Aug 3, 2022 |